Exelixis (EXEL) Return on Equity [ROE] (2011 - 2026)
Exelixis (EXEL) recorded Return on Equity [ROE] of 45.54% in Q2 2027, up 16.62 percentage points from 28.92% a year earlier and up 4.86 percentage points from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2026, Exelixis reported Return on Equity [ROE] of 35.53%, up 12.40 percentage points from FY2025.
- Annual Return on Equity [ROE] has a five-year change of +24.23 percentage points (FY2021 to FY2026).
- Across earlier years, Return on Equity [ROE] came in at 23.13% in FY2025, 8.74% in FY2023 (+0.99 pp) and 7.76% in FY2022 (-3.54 pp).
- The Q2 2027 figure is the highest quarterly Return on Equity [ROE] since Q1 2020.
- On a year-over-year basis, Return on Equity [ROE] has increased for six consecutive quarters, with an average year-over-year change of +14.11 percentage points over the last six quarters.
- Per Business Quant, the preceding three quarters came in at 40.68% (Q1 2027), 36.21% (Q4 2026) and 32.33% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn | 45.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 45.54% |
| Apr 3, 2026 | 40.68% |
| Jan 2, 2026 | 36.21% |
| Oct 3, 2025 | 32.33% |
| Jul 4, 2025 | 28.92% |
| Apr 4, 2025 | 29.42% |
| Jan 3, 2025 | 23.07% |
| Sep 27, 2024 | 21.25% |
| Jun 28, 2024 | 16.48% |
| Mar 29, 2024 | 9.34% |
| Dec 29, 2023 | 9.01% |
| Sep 29, 2023 | 3.78% |
| Jun 30, 2023 | 6.46% |
| Mar 31, 2023 | 6.10% |
| Dec 30, 2022 | 7.32% |
| Sep 30, 2022 | 12.60% |
| Jul 1, 2022 | 11.64% |
| Apr 1, 2022 | 13.23% |
| Dec 31, 2021 | 10.69% |
| Oct 1, 2021 | -0.22% |
API Access
Exelixis Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();